Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal

DOI: 10.2122/gbc.2008.0086


VEGF and EGFR Antagonists for Gastric Cancer

Prof. Dr. Johannes Zacherl


Since there is no abstract, we provide the first paragraph

The idea of the dependence of tumor growth and metastasis on blood vessels was published for the first in the 1970s [1]. Tumor anti-angiogenesis is a rational target for therapy. Although accumulating preclinical evidence supports this hypothesis there is still moderate overall survival benefit in patients with metastatic colorectal and lung cancer, No positive adjuvant trial has reported improved cure by adding anti-angiogenic agents to cytotoxic chemotherapy for any cancer type.

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 3 February 2004